Legend Biotech Corporation vs UnitedHealth Group Incorporated — Stock Comparison

LEGN
Legend Biotech Corporation
$23.59
▲ 0.30%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.9/10

Q·Score Breakdown

5.9
Neutral
Overall
6.3
Neutral
0.2
Quality
6.2
7.6
Health
5.3
5.5
Growth
5.1
9.7
Valuation
7.3
8.3
Sentiment
8.1
LEGN

Consensus analyst target of $57.23 is 143% above current price.

currently unprofitable (-29% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $57.23 (+142.6%)
16 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

LEGN
UNH
Trailing P/E
27.9×
20.5×
Forward P/E
17.8×
-28.8%
Profit Margin
2.7%
20.0%
Gross Margin
18.8%
-29.1%
ROE
12.2%
64.2%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.08
Beta
0.41
Price / Book
$4.4B
Market Cap
$334.9B
$16 – $45
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →